These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 18220622)
1. Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component. Kles KA; Vinik AI Curr Diabetes Rev; 2006 May; 2(2):131-45. PubMed ID: 18220622 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of diabetic peripheral neuropathy. Ziegler D Diabet Med; 1996; 13 Suppl 1():S34-8. PubMed ID: 8741827 [No Abstract] [Full Text] [Related]
11. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine. Kawai T; Takei I; Tokui M; Funae O; Miyamoto K; Tabata M; Hirata T; Saruta T; Shimada A; Itoh H J Diabetes Complications; 2010; 24(6):424-32. PubMed ID: 19716319 [TBL] [Abstract][Full Text] [Related]
12. The diabetic neuropathies. Gooch C; Podwall D Neurologist; 2004 Nov; 10(6):311-22. PubMed ID: 15518597 [TBL] [Abstract][Full Text] [Related]
13. [Diabetic neuropathy]. Chudzik W; Kaczorowska B; Przybyła M; Chudzik B; Gałka M Pol Merkur Lekarski; 2007 Jan; 22(127):66-9. PubMed ID: 17477095 [TBL] [Abstract][Full Text] [Related]
15. Diabetic neuropathies. Vinik AI; Mehrabyan A Med Clin North Am; 2004 Jul; 88(4):947-99, xi. PubMed ID: 15308387 [TBL] [Abstract][Full Text] [Related]
16. Diabetes and the nervous system. Harati Y Endocrinol Metab Clin North Am; 1996 Jun; 25(2):325-59. PubMed ID: 8799703 [TBL] [Abstract][Full Text] [Related]
17. [Examination of questionnaires regarding diabetic peripheral neuropathy in epalrestat-treated patients and their usefulness in the treatment of the patients during the treatment course]. Ito A; Ishii-Nozawa R; Ibuki C; Atarashi H; Kataoka H; Takeuchi K Yakugaku Zasshi; 2009 Oct; 129(10):1239-47. PubMed ID: 19797880 [TBL] [Abstract][Full Text] [Related]
18. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. Valensi P; Giroux C; Seeboth-Ghalayini B; Attali JR J Diabetes Complications; 1997; 11(1):27-34. PubMed ID: 9025010 [TBL] [Abstract][Full Text] [Related]
19. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Argoff CE; Cole BE; Fishbain DA; Irving GA Mayo Clin Proc; 2006 Apr; 81(4 Suppl):S3-11. PubMed ID: 16608048 [TBL] [Abstract][Full Text] [Related]